COSENTYX Monthly Dosing Schedule for PsA

  • Each 300-mg dose is given as 2 subcutaneous injections of 150 mg

For other PsA patients:

  • Recommended dose of 150 mg
  • Administer with or without a loading dose§
  • COSENTYX may be administered with or without methotrexate
  • If a patient continues to have active psoriatic arthritis, consider a dosage of 300 mg

*Monthly maintenance dose=1 dose every 4 weeks.

The first self-injection should be performed under the supervision of a qualified healthcare professional. Patients should be trained in proper injection technique prior to self-administration.

For some patients, a dose of 150 mg may be acceptable.

§Without a loading dose is 150 mg every 4 weeks.

COSENTYX® (secukinumab) is available in Sensoready® pens1

COSENTYX Sensoready Pens for PsA

  • Each Sensoready pen contains 150 mg/mL of COSENTYXII
    • Each 300-mg/mL package contains two 150-mg/mL Sensoready pens
    • Each 150-mg/mL package contains one 150-mg/mL Sensoready pen
  • Prefilled syringes are also available—each contains 150 mg/mLII

IIThe removable cap of the COSENTYX Sensoready pen and the prefilled syringe contains natural rubber latex and should not be handled by latex-sensitive individuals. The safe use of the COSENTYX Sensoready pen or prefilled syringe in latex-sensitive individuals has not been studied.1

COSENTYX Demo Kit: Help your staff teach new patients how to inject COSENTYX. View the supplemental demonstration video here. Or ask your local representative about how to get a COSENTYX demo kit for your office.

PsA=psoriatic arthritis.

Reference: 1. Cosentyx [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2016.